Corneal thickness recovers after CXL

Article

After a corneal collagen cross-linking (CXL) procedure a patient's cornea thins but then recovers towards original thickness.

After a corneal collagen cross-linking (CXL) procedure a patient's cornea thins but then recovers towards original thickness, according to a one-year follow-up study published in the Journals of Cataract and Refractive Surgery.

Dr Peter S. Hersh et al., Cornea and Laser Eye Institute, New Jersey, USA, studied 54 eyes with keratoconus and 28 eyes with ecstasia after LASIK. The outcome measures were corneal thickness at the apex, the thinnest point and the pupil centre. These were measured at baseline and 1, 3, 6 and 12 months post-CXL.

Mean preoperative thinnest pachymetry was 440.7 μm ± 52.9 SD. Apex and corneal thickness returned to baseline after 1 year. Corneal thickness recovered more rapidly in ecstasia patients than in keratoconus patients. Although the researchers found that the corneal thickness was reduced up to 3-months post-op, the baseline thickness was recovered at 3 to 6-months follow-up.

In conclusion, the baseline thickness of the cornea is recovered after CXL but the causes and possible effects of this change in thickness still need to be explained.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.